A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2006
10/25/2006	CN1852979A Modulation of eIF4E expression
10/25/2006	CN1852921A Soluble fragments of the SARS-cov spike glycoprotein
10/25/2006	CN1852920A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/25/2006	CN1852919A Agonist polypeptide of receptor for ZOT and zonulin
10/25/2006	CN1852917A Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
10/25/2006	CN1852741A Compounds and methods for downregulating the effects of TGF-beta
10/25/2006	CN1852737A Combination of a histone deacetylase inhibitor with a death receptor ligand
10/25/2006	CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006	CN1852732A Polymer conjugates of interferon-beta with enhanced biological potency
10/25/2006	CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006	CN1852730A Modulators of P-selectin glycoprotein ligand 1
10/25/2006	CN1852729A Antibacterial drug for propionibacterium acnes
10/25/2006	CN1852728A Host defense factor X (HDFX)
10/25/2006	CN1852727A Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
10/25/2006	CN1852722A Methods and pharmaceutical compositions for healing wounds
10/25/2006	CN1852716A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
10/25/2006	CN1852711A Infection prophylaxis using immune response modifier compounds
10/25/2006	CN1852665A Infant formula
10/25/2006	CN1850977A Soluble colibacillus expression plasmid and its use
10/25/2006	CN1850976A Glucose kinase derivant for inhibiting platelet aggregation and thrombase activity, and its preparing method
10/25/2006	CN1850857A Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use
10/25/2006	CN1850278A Polyethyleneglyol modified recombinant human B lymphocyte stimulating factor and its preparing method
10/25/2006	CN1850270A Ovotransferrin iron supplement agent, and its preparing method and use
10/25/2006	CN1850269A Function of GPR39 gene for central nervous system of mammal and its use
10/25/2006	CN1281758C Eukaryotic expression vector of ER-detented IV collagenase cellular antibody gene
10/25/2006	CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
10/25/2006	CN1281743C Preparation method of earthworm kinase dry powder
10/25/2006	CN1281742C Polycondensed amino-acid coordinated SOD simulatives
10/25/2006	CN1281625C WT1 modified peptide
10/25/2006	CN1281624C Thrombin derivatives and its process for production
10/25/2006	CN1281623C Human alpha interferon derivative with superstrong antiviral activity
10/25/2006	CN1281621C Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point
10/25/2006	CN1281619C Process for preparing glycopeptide derivatives
10/25/2006	CN1281618C Novel depsipeptide compound
10/25/2006	CN1281272C Interferon effervescence capsule for vagina used and its preparation method
10/25/2006	CN1281271C Biological bacteria inhibitor
10/25/2006	CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125975 Derivatized oligonucleotides having improved uptake and other properties
10/24/2006	US7125970 Host cells; drug screening; antigrowth agents
10/24/2006	US7125969 Diagnosis; prognosis; transcription factors
10/24/2006	US7125963 Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
10/24/2006	US7125961 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/24/2006	US7125959 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
10/24/2006	US7125958 membrane proteins acting as binding ligands to mucopolysaccharide receptors for antigens present on the surfaces of palsmodium infected erythrocytes; drugs; antibodies
10/24/2006	US7125957 VPR mutant protein and its encoding gene having apoptosis-inducing action
10/24/2006	US7125956 Peptide fragment of interleukin 1 beta converting enzyme (ICE) itself as ICE inhibitors; peptide is linked to an agent capable of specifically directing the compound to a cell such as fragment of Antennepedia polypeptide, an antibody, an adjuvant or a cell-specific ligand; neurodegenerative disorders
10/24/2006	US7125955 mitotic kinase, NIMA, encoded by the Aspergillus nimA gene; pure WW domain of a Pin1 polypeptide which interacts with NIMA; a Peptidyl-prolyl cis/trans isomerases (PPIase); drug target; Pin1 is a PPIase known to be essential for life
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125872 protease/thrombin inhibitors
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125857 A synthetic oligonucleotide comprising a C-5 methylcytosine recognizes and binds an allosteric site on DCTMase and suppressed its catalytic activity; anticarcinogenic and tumor agents; developmental disorders; drug resistance
10/24/2006	US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006	US7125851 Endoprosthesis with long-term stability
10/24/2006	US7125850 Growth Arrest and DNA Damage-inducible gene 45 (GADD45); for sensitizing proliferating cells by adminstering antibodies; liposomes
10/24/2006	US7125849 Peptide-based angiogenesis inhibitors and methods of use thereof
10/24/2006	US7125848 Administering conotoxins
10/24/2006	US7125847 polypeptides isolated from spider venoms, used as antiarrhythmia agents; cardiovascular disorders
10/24/2006	US7125846 Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
10/24/2006	US7125845 Aza-peptide macrocyclic hepatitis C serine protease inhibitors
10/24/2006	US7125844 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
10/24/2006	US7125842 Anti-fungal compounds and methods of use
10/24/2006	US7125841 Mutants and heparin for blood disorders
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125838 Peptides containing N-substituted L-amino acids for preventing β-strand association
10/24/2006	US7125837 Elastin-based compositions
10/24/2006	US7125836 Method of cancer screening; method of cancer treatment; and method of diabetes treatment
10/24/2006	US7125726 Method and kit for diagnosing myocardial infarction
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125702 Preparation of an proteolytic enzymatic hydrolysate of a selected soybean storage protein fraction, glycinin, that evidences potent Angiotensin Converting Enzyme inhibitory activity.
10/24/2006	US7125698 Polynucleotides isolated from Lactobacillus rhamnosus, oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, organisms incorporating them
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125689 Method for rendering streptokinase less immunogenic to a human
10/24/2006	US7125688 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein
10/24/2006	US7125687 Presenilin enhancers assays
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125683 Preparations for diagnosis extrapancreatic secretory function
10/24/2006	US7125677 NIMA interacting proteins
10/24/2006	US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/24/2006	US7125568 Lipophilic drug compositions
10/24/2006	US7125566 Particulate drug-containing products and method of manufacture
10/24/2006	US7125559 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006	US7125554 Engineered superantigen for human therapy
10/24/2006	US7125546 Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2006	US7125542 Methods and compositions for treating conditions of the eye
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/24/2006	CA2276587C Silicone core long term androgen delivery implant
10/24/2006	CA2275587C Injectable depot gel composition and method of preparing the composition
10/24/2006	CA2261848C Cell adhesion inhibitors
10/20/2006	WO2007045090A1 Ultra high pressure modified proteins and uses thereof
10/20/2006	WO2005097173A2 Use of ghrelin for the treatment of hyperthyroidism
10/20/2006	CA2666960A1 Ultra high pressure modified proteins and uses thereof

1 ... 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 ... 3163